Adjuvia Therapeutics: Funding, Investors & Team (Sep 2026)
Adjuvia Therapeutics is a clinical-stage biopharmaceutical company.
Adjuvia Therapeutics has raised $8.0M across 1 funding round on record, the most recent a Seed of $8.0M announced in Jul 2026.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Adjuvia Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Adjuvia Therapeutics Funding Rounds
Adjuvia Therapeutics Investors
Adjuvia Therapeutics Founders and Leadership Team
Contact details for the Adjuvia Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Adjuvia Therapeutics Funding Compared to Other Biotechnology Startups
Adjuvia Therapeutics' latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Adjuvia Therapeutics in Biotechnology and San Francisco
Companies Similar to Adjuvia Therapeutics
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Adjuvia Therapeutics Funding FAQs
What does Adjuvia Therapeutics do?
Adjuvia Therapeutics is a clinical-stage biopharmaceutical company.
How much funding has Adjuvia Therapeutics raised?
Adjuvia Therapeutics has raised $8.0M across 1 round on record. The most recent is a Seed of $8.0M announced in Jul 2026.
When did Adjuvia Therapeutics last raise funding?
Adjuvia Therapeutics' most recent funding round on record is a Seed of $8.0M, announced in Jul 2026.
Who has invested in Adjuvia Therapeutics?
Investors on record for Adjuvia Therapeutics include Portfolia, JLo Ventures.
Who founded Adjuvia Therapeutics?
FundedIQ lists Laura Glickman (Co-Founder and CEO) at Adjuvia Therapeutics.
Where is Adjuvia Therapeutics headquartered?
Adjuvia Therapeutics is based in San Francisco, United States.
How many employees does Adjuvia Therapeutics have?
Adjuvia Therapeutics is in the 1-10 employee band.
When was Adjuvia Therapeutics founded?
Adjuvia Therapeutics was founded in 2023.
How does Adjuvia Therapeutics' funding compare to other Biotechnology startups?
Adjuvia Therapeutics' latest round of $8.0M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Adjuvia Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Adjuvia Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.